share_log

健民集团(600976.SH)：目前龙牡壮骨颗粒渠道库存持续下降，其中60袋的渠道库存已接近目标水平

Jianmin Pharmaceutical Group (600976.SH): Currently, channel inventory of Longmu Zhuanggu particles continues to decline, with channel inventory of 60 bags approaching target levels.

Gelonghui Finance ·  Jul 3 03:55

Jianmin Pharmaceutical Group (600976.SH) stated during a specific object investigation that since 2024, the company's marketing assessment model has transformed from issuing assessments to pure sales assessments while appropriately reducing promotions. Sales of Longmu Strong Bone Granules were slightly reduced in the first quarter, but channel inventory continued to decline, and pure sales remained stable. As the company's marketing digital system is gradually advancing, the accuracy of pure sales data still needs to be further verified. The company's product channel control work is continuously being carried out, and pure sales efforts will continue to be increased in order to strive for a more healthy level of channel inventory. Currently, the channel inventory of Longmu Strong Bone Granules continues to decline, with the channel inventory of 60 bags approaching the target level, while the channel inventory of 30 bags is slightly higher than that of the 60 bags and will be adjusted as soon as possible.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment